Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

Completed · Phase 1 · Has a placebo group

Conditions studied: Erectile Dysfunction

In brief

The objective of this study is to evaluate the hemodynamic response to a sublingual dose of glyceryl trinitrate in subjects receiving oral TA-1790, sildenafil citrate, and placebo.

Key facts

Study ID

NCT01616485

Run by

VIVUS LLC

People needed

106

Starts

2004-03-01

Expected to finish

2004-05-01

Last updated by the study team

2012-06-14

Who can join

Age: 30 and older, up to 60. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Provide written informed consent
• Willing to comply with all study requirements and clinic schedules
• Male between 30 to 60 years of age
• Non-smoker
• No history of alcohol abuse
• Normal screening laboratory values

You may not qualify if…

• Allergy or hypersensitive to PDE5 inhibitors
• Evidence of clinically significant disease
• Supine systolic/diastolic blood pressure level
• History of cardiovascular disease
• Previously participated in TA-1790 within the past 30 days

Where it is running

• MDS Pharma Services — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.